B16 HER2/HER3 pathway in biliary tract cancers: a systematic review and meta-analysis. A novel therapeutic druggable target?
Affiliation
Istituto Europeo di Oncologia, MilanoIssue Date
2016-09-21
Metadata
Show full item recordCitation
B16 HER2/HER3 pathway in biliary tract cancers: a systematic review and meta-analysis. A novel therapeutic druggable target? 2016, 27(suppl_4): iv22 Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw333.16Additional Links
https://academic.oup.com/annonc/article/27/suppl_4/iv22/2770160/B16HER2-HER3-pathway-in-biliary-tract-cancers-aType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw333.16